Historic FDA approval: Flow FL-100 becomes the first FDA-approved at-home brain stimulation device for moderate to severe ...
Treatment with ECT showed a significant decrease in the odds of suicide (odds ratio [OR], 0.66) and for death from all causes (OR, 0.70). HealthDay News — Electroconvulsive therapy (ECT) shows a ...
Since the start of the COVID pandemic, there has been more attention given to problems of mental ill-health including depression than ever before. A new therapeutic option, especially for depression, ...
ECT response–guided sequential strategy. This strategy comprises two phases. In the initial phase, the goal is to exploit the advantage of ECT in rapidly inducing mood improvement and then to ...
New FDA approval: Flow FL-100 becomes the first at-home, non-drug brain stimulation device cleared for moderate to severe depression in non–medication-resistant patients. How it works: The Bluetooth ...